Our organization is committed to advancing medical research by conducting a wide range of scientific studies. These studies contribute to the development of new treatments, improved healthcare solutions, and a deeper understanding of various medical conditions.

Ongoing Research Studies

Our active research studies focus on multiple therapeutic areas, involving collaborations between board-certified physicians, research institutions, and industry leaders. Below are some of our ongoing research initiatives:

1) Neurological Research

Overview: Investigating the latest advancements in neurodegenerative diseases such as Alzheimer’s and Parkinson’s Disease to improve diagnosis and treatment options.
Study Focus: Cognitive function, disease progression, and innovative therapeutic approaches.

2) Psychiatric Studies

Overview: Exploring new interventions for mental health conditions, including depression, anxiety, and schizophrenia, with a focus on improving patient outcomes.
Study Focus: Behavioral health patterns, neurobiological factors, and novel treatment methods.

3) Cardiovascular Research

Overview: Studying heart health, risk factors, and emerging treatments for cardiovascular diseases to enhance patient care.
Study Focus: Preventive strategies, early diagnosis, and new medical interventions.

4) Pediatric Healthcare Studies

Overview: Conducting research on pediatric diseases, vaccinations, and early childhood development to ensure better healthcare outcomes for children.
Study Focus: Immunization, genetic disorders, and innovative pediatric treatments.

5) Oncology Research

Overview: Investigating novel cancer therapies and the effectiveness of personalized treatment options for various types of cancer.
Study Focus: Targeted therapies, patient response analysis, and new drug developments.

6) Olvi-Vec-NSCLC-025: Advancing Treatment for Non-Small Cell Lung Cancer

Overview: Olvi-Vec-NSCLC-025 is a clinical study focused on developing innovative treatments for non-small cell lung cancer (NSCLC). This study evaluates targeted therapies and immunotherapy approaches to improve patient outcomes.
Study Focus: Evaluating targeted therapies, immunotherapy approaches, and novel treatment combinations to improve NSCLC patient outcomes.

Why Participate in a Research Study?

• Contribute to groundbreaking medical discoveries.
• Access expert medical care from leading researchers.
• Help advance treatments that may benefit future generations.

Our Research Locations

Our research studies are conducted at multiple locations to provide convenient access to participants. Some of our key research sites include:

• Complete Cardiac Care – Houston, TX
• Texas Behavioral Healthcare – Pasadena, TX
• Texas Behavioral Health – Friendswood, TX
• Steven Goldstein & Associates – Houston, TX
• HCA Houston Healthcare – Katy, TX
• HCA Houston Healthcare – Baytown, TX
• Gentle Pediatrics – Sugar Land, TX